moxidectin and fluphenacur

moxidectin has been researched along with fluphenacur* in 2 studies

Trials

2 trial(s) available for moxidectin and fluphenacur

ArticleYear
Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired toxocara canis infections in dogs.
    Veterinary therapeutics : research in applied veterinary medicine, 2002,Fall, Volume: 3, Issue:3

    The efficacy of moxidectin injection (ProHeart 6 Sustained Release Injectable for Dogs, Fort Dodge Animal Health) against naturally acquired infections of Toxocara canis was compared with that of milbemycin oxime/lufenuron tablets (Sentinel Flavor Tabs, Novartis Animal Health). Eighteen dogs with naturally acquired infections of T. canis were ranked by egg counts and randomly assigned to treatment with moxidectin (170 micro g/kg), milbemycin (500 micro g/kg)/lufenuron (10 mg/kg), or to an untreated control group (six dogs per treatment). Dogs were euthanized 7 days after treatment for recovery, identification, and enumeration of parasites by species. There was no apparent efficacy for moxidectin against T. canis. Conversely, milbemycin oxime/lufenuron was 91.5 % effective against naturally occurring infections of this canine parasite.

    Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Autopsy; Benzamides; Delayed-Action Preparations; Dog Diseases; Dogs; Drug Combinations; Female; Injections; Macrolides; Male; Tablets; Toxocara canis; Toxocariasis

2002
Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired trichuris vulpis infections in dogs.
    Veterinary therapeutics : research in applied veterinary medicine, 2002,Fall, Volume: 3, Issue:3

    Efficacy of moxidectin injection (ProHeart 6 Sustained Release Injectable for Dogs, Fort Dodge Animal Health) against naturally acquired infections of Trichuris vulpis was compared with that of milbemycin oxime/lufenuron tablets (Sentinel Flavor Tabs, Novartis Animal Health). Eighteen dogs infected with T. vulpis were ranked by egg counts and randomly allocated to treatment with moxidectin (170 micro g/kg), milbemycin (500 micro g/kg)/lufenuron (10 mg/kg), or to an untreated control group (six dogs per treatment). Dogs were euthanized for worm counting 7 days after treatment. Efficacy of milbemycin/lufenuron against T. vulpis was 99.6 %, compared with 67.5 % for moxidectin. The commercial formulation of milbemycin oxime/lufenuron provided excellent control of whipworm infection, whereas moxidectin demonstrated variable efficacy against this parasite.

    Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Autopsy; Benzamides; Delayed-Action Preparations; Dog Diseases; Dogs; Drug Combinations; Female; Injections; Macrolides; Male; Tablets; Trichuriasis; Trichuris

2002